Search details
1.
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Oncologist
; 27(7): 534-e546, 2022 07 05.
Article
in English
| MEDLINE | ID: mdl-35285484
2.
Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma.
Future Oncol
; 17(6): 675-688, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33070660
3.
Trends in utilization, conversion rates, and outcomes for minimally invasive approaches to non-metastatic rectal cancer: a national cancer database analysis.
Surg Endosc
; 35(6): 3154-3165, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32601761
4.
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Pancreatology
; 20(6): 1115-1122, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32778368
5.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31787526
6.
A comparison of teaching opportunities for rural and urban family medicine residents.
Med Educ
; 54(2): 162-170, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31822039
7.
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
Oncologist
; 24(5): 589-e160, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30679315
8.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
BMC Cancer
; 17(1): 137, 2017 02 15.
Article
in English
| MEDLINE | ID: mdl-28202004
9.
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Invest New Drugs
; 34(1): 96-103, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26581401
10.
Building pathways to healthcare education with Indigenous youth: An integrative approach.
Med Educ
; 55(5): 653, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33725743
11.
Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.
Invest New Drugs
; 33(4): 963-8, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25952464
12.
Peer support: A medical student-driven mental health workshop.
Med Educ
; 54(5): 469-470, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32227496
13.
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.
Oncologist
; 19(5): 492-7, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24710310
14.
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors.
Invest New Drugs
; 32(4): 710-6, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24740268
15.
Corrigendum: Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies.
Front Immunol
; 15: 1378003, 2024.
Article
in English
| MEDLINE | ID: mdl-38380313
16.
Technologies in the wild (TiW): human factors implications for patient safety in the cardiovascular operating room.
Ergonomics
; 56(2): 205-19, 2013.
Article
in English
| MEDLINE | ID: mdl-23384283
17.
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Endocr Relat Cancer
; 30(11)2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37702588
18.
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies.
Front Immunol
; 14: 1230049, 2023.
Article
in English
| MEDLINE | ID: mdl-37795086
19.
Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
Liver Transpl
; 18(5): 594-601, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22140024
20.
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.
Invest New Drugs
; 30(1): 387-94, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-20839030